ZA879093B - Azole derivatives - Google Patents

Azole derivatives

Info

Publication number
ZA879093B
ZA879093B ZA879093A ZA879093A ZA879093B ZA 879093 B ZA879093 B ZA 879093B ZA 879093 A ZA879093 A ZA 879093A ZA 879093 A ZA879093 A ZA 879093A ZA 879093 B ZA879093 B ZA 879093B
Authority
ZA
South Africa
Prior art keywords
azole derivatives
azole
derivatives
Prior art date
Application number
ZA879093A
Other languages
English (en)
Inventor
Helmut Egger
Egger Helmut
Rudolf Waelchli
Waelchli Rudolf
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA879093B publication Critical patent/ZA879093B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA879093A 1986-12-03 1987-12-03 Azole derivatives ZA879093B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3641320 1986-12-03

Publications (1)

Publication Number Publication Date
ZA879093B true ZA879093B (en) 1989-07-26

Family

ID=6315380

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879093A ZA879093B (en) 1986-12-03 1987-12-03 Azole derivatives

Country Status (24)

Country Link
JP (1) JPH0678318B2 (ko)
KR (1) KR880007481A (ko)
AT (1) AT395587B (ko)
AU (1) AU605522B2 (ko)
BE (1) BE1001235A4 (ko)
CH (1) CH677925A5 (ko)
DK (1) DK631287A (ko)
ES (1) ES2010235A6 (ko)
FI (1) FI875300A (ko)
FR (1) FR2607810B1 (ko)
GB (1) GB2199579B (ko)
GR (1) GR871897B (ko)
HU (1) HU198694B (ko)
IL (1) IL84665A (ko)
IT (1) IT1211944B (ko)
LU (1) LU87063A1 (ko)
MY (1) MY103004A (ko)
NL (1) NL8702897A (ko)
NZ (1) NZ222765A (ko)
PH (1) PH24666A (ko)
PL (1) PL151588B1 (ko)
PT (1) PT86255B (ko)
SE (1) SE8704792L (ko)
ZA (1) ZA879093B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
RO114129B1 (ro) * 1991-09-02 1999-01-29 Yamanouchi Pharmaceutical Co., Ltd. Derivaţi aminici terţiari substituiţi cu triazolil
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT382868B (de) * 1983-03-11 1987-04-27 Sandoz Ag Verfahren zur herstellung neuer azolderivate und deren salze
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法

Also Published As

Publication number Publication date
NL8702897A (nl) 1988-07-01
CH677925A5 (ko) 1991-07-15
FI875300A0 (fi) 1987-12-01
BE1001235A4 (fr) 1989-08-29
FR2607810B1 (fr) 1989-12-01
AU8196287A (en) 1988-06-16
GB8727978D0 (en) 1988-01-06
DK631287A (da) 1988-06-04
SE8704792L (sv) 1988-06-04
IT1211944B (it) 1989-11-08
JPH0678318B2 (ja) 1994-10-05
PT86255A (en) 1988-06-01
AU605522B2 (en) 1991-01-17
SE8704792D0 (sv) 1987-12-01
NZ222765A (en) 1990-11-27
PL151588B1 (en) 1990-09-28
IL84665A0 (en) 1988-05-31
GR871897B (en) 1988-04-04
PH24666A (en) 1990-09-07
ATA316887A (de) 1992-06-15
LU87063A1 (fr) 1988-07-14
KR880007481A (ko) 1988-08-27
PL269180A1 (en) 1988-08-18
GB2199579B (en) 1990-07-18
HUT45506A (en) 1988-07-28
ES2010235A6 (es) 1989-11-01
IT8748656A0 (it) 1987-12-01
HU198694B (en) 1989-11-28
FR2607810A1 (fr) 1988-06-10
MY103004A (en) 1993-03-31
AT395587B (de) 1993-01-25
IL84665A (en) 1991-11-21
FI875300A (fi) 1988-06-04
GB2199579A (en) 1988-07-13
JPS63145270A (ja) 1988-06-17
PT86255B (pt) 1990-11-07
DK631287D0 (da) 1987-12-01

Similar Documents

Publication Publication Date Title
GB2190676B (en) Imidazoquinolinylether derivatives
ZA878159B (en) Reduced avermecting derivatives
GB8621648D0 (en) Azole derivatives
GB8617652D0 (en) Acylanilide derivatives
GB8719310D0 (en) Piperidylaminotriazine derivatives
GB2198132B (en) 1-piperazinylpyrimidine derivatives
GB8629875D0 (en) Pyridazodiazepine derivatives
GB8709654D0 (en) Pyrazole derivatives
GB2185483B (en) Pyroglutamide derivatives
EP0247381A3 (en) 5-flurorouracil derivatives
GB2198729B (en) Azaspirodecane derivatives
EP0269839B1 (en) 5-acylamino-pyrazole derivatives
AR245109A1 (es) Un procedimiento para la preparacion de 5-fenil-5h-indeno/1,2-d/ pirimidina.
GB2199579B (en) Azole derivatives
GB8617083D0 (en) Imidazole derivatives
EP0246002A3 (en) Alkenamide derivatives
GB2186575B (en) Abietamide derivatives
GB2189487B (en) Ergolene derivatives
ZA895477B (en) Azole derivatives
EP0267024A3 (en) Hydrofluorene derivatives
GB8612161D0 (en) Azole derivatives
GR870728B (en) Tetrahydronaphalin derivatives
IE861349L (en) Azole derivatives
EP0244193A3 (en) Dihalogen-substituted thiocyanopyrimidine derivatives
GB8705006D0 (en) 5-acyloxy-13beta-alkyl-milbemycin derivatives